Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Sonrotoclax | 2383086-06-2 | 99.61% | 890.10 | 25 MG
SDP

Supplier:  Medchemexpress LLC 25MGHY148026

Encompass_Preferred

Sonrotoclax is a potent, orally active Bcl2 inhibitor that exhibits an effective cell-killing effect against various lymphoma and leukemia cell lines. It demonstrates antineoplastic activity and inhibits tumor growth in relevant models.

  • Potent, orally active Bcl2 inhibitor
  • Effective cell-killing effect against various lymphoma and leukemia cell lines
  • Exhibits antineoplastic activity
  • Inhibits tumor growth
  • For research use only

Catalog No. 50-003-62631


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.